Company Number: NI669184

Analysis Date: 2025-07-20 13:02 UTC

Financial Health Assessment: BERKO POD SYSTEMS LTD

---

1. Financial Health Score: B

Explanation:
Berko Pod Systems Ltd demonstrates a solid and improving financial position typical of a young micro-entity business. Key indicators such as net assets and net current assets have shown consistent growth, reflecting healthy capital accumulation and liquidity. The company’s balance sheet shows no alarming signs of distress but remains in an early growth phase, warranting ongoing monitoring for sustained profitability and cash flow management.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets	£18,435	Moderate investment in long-term assets; slight decrease from prior year suggests cautious asset management.
Current Assets	£312,027	Strong growth (almost doubled from prior year); healthy "cash and receivables" pool indicating good liquidity.
Current Liabilities	£172,855	Increase in short-term obligations; needs monitoring but covered well by current assets.
Net Current Assets	£139,172	Positive and growing working capital signals ability to cover short-term debts comfortably.
Net Assets (Shareholders’ Funds)	£152,104	Steady increase from £54,055 in prior year; shows retained earnings and equity injections improving company solvency.
Average Employees	2	Small team size consistent with micro entity status; manageable payroll obligations.
Share Capital	£2.00	Minimal nominal capital, typical for micro private limited companies; equity growth through retained profits.

---

3. Diagnosis: The Financial Pulse of Berko Pod Systems Ltd

• Healthy Cash Flow and Liquidity: The company exhibits a robust liquidity position with current assets comfortably exceeding current liabilities by £139K, a strong sign of short-term financial health akin to a patient with a steady heartbeat. This "working capital cushion" suggests the business is well-positioned to meet its immediate obligations and invest in growth.

• Growth in Net Assets: The significant increase in net assets from £54K to £152K over one year is encouraging, indicating profitable operations or equity injections. This healthy "capital build-up" is similar to a patient gaining strength and resilience.

• Stable Fixed Asset Base: Fixed assets have slightly decreased, which may indicate asset disposals or cautious capital expenditure. The company is maintaining a lean asset base, typical for a start-up or micro business, focusing resources on operational liquidity rather than heavy investment.

• Micro-Entity Status: As a micro company, the business benefits from simplified reporting but should ensure compliance with filing deadlines to avoid any regulatory "symptoms" such as penalties.

• Director and Governance: The presence of three current directors, including recent appointments, suggests active governance and possibly an injection of new strategic perspectives.

• Industry Context: Operating in specialised construction activities (SIC 43999), the company is likely subject to project-based revenue, requiring tight cash flow management to avoid liquidity "stress."

---

4. Recommendations: Prescriptions for Financial Wellness

• Maintain Strong Working Capital: Continue to monitor current asset and liability balances closely. Avoid excessive short-term debt accumulation which could strain liquidity. Consider negotiating extended payment terms with suppliers to improve cash flow cycles.

• Build Profitability and Retain Earnings: Focus on increasing profit margins through operational efficiency and cost control. The growing net assets are a positive symptom; aim to sustain this trend for long-term solvency.

• Consider Capital Structure Review: With minimal share capital, explore options for equity injections or retained earnings reinvestment to support growth initiatives without over-relying on debt.

• Asset Management: Review fixed asset utilization to ensure investments are aligned with business strategy, avoiding unnecessary capital lock-in.

• Compliance Vigilance: Remain diligent about filing deadlines and statutory obligations to prevent penalties or regulatory complications, which can act as financial toxins.

• Strategic Planning: As the company grows, consider formal budgeting and forecasting processes to anticipate future "health challenges" and enable proactive management.

---